CurrentUnitedHealthcarePolicy BIP003.P

Allergy Testing and Injections

Customize your policy alerts

Sign up for UnitedHealthcare Policy BIP003.P alerts

Get alerted when Policy BIP003.P changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

This policy governs coverage for allergy testing, allergy serum, supplies, and allergy treatment services for UnitedHealthcare of California HMO and UnitedHealthcare Benefits Plan of California EPO/POS members. Coverage is subject to medical necessity, the member's Evidence of Coverage or Schedule of Benefits, and applicable network and treatment-plan requirements.

Policy Summary

PayerUnitedHealthcare

PolicyAllergy Testing and Injections

Policy CodePolicy BIP003.P

Change TypeNo material change

Effective DateOctober 1, 2026

Next Review DateNot specified

Key ActionVerify and document the member's applicable Evidence of Coverage or Schedule of Benefits and any state market plan benefit provisions.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

3Non-covered tests or services

3Covered benefit categories

1Related benefit interpretation policies

CAApplicable state market

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentUnitedHealthcarePolicy BIP003.P

Allergy Testing and Injections

Customize your policy alerts

Sign up for UnitedHealthcare Policy BIP003.P alerts

Get alerted when Policy BIP003.P changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerUnitedHealthcare

PolicyAllergy Testing and Injections

Policy CodePolicy BIP003.P

Change TypeNo material change

Effective DateOctober 1, 2026

Next Review DateNot specified

Key ActionVerify and document the member's applicable Evidence of Coverage or Schedule of Benefits and any state market plan benefit provisions.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

3Non-covered tests or services

3Covered benefit categories

1Related benefit interpretation policies

CAApplicable state market

Covered and Non-Covered Allergy Services

Allergy serum and treatment

All of the following requirements apply for covered allergy serum and treatment services.

Coverage requirements: Allergy serum, including needles, syringes, and other administration supplies, is used for treatment of allergies; the serum and supplies are obtained through a UnitedHealthcare network physician; and allergy treatment, including allergen or antigen immunotherapy and serum, is provided according to an established treatment plan.

All services must also be medically necessary.

Allergy testing and diagnostic services

Covered allergy testing may include the following services when clinically indicated.

Covered allergy testing and services: Provocative antigen testing to determine appropriate allergy treatment; complete blood count with differential, such as eosinophil count; chest X-ray when respiratory symptoms are present; skin testing; total gamma globulins; or radioallergosorbent test (RAST) when skin testing is unsuccessful or not tolerated due to an existing skin condition.

The listed examples are not exhaustive; additional testing may be covered when clinically indicated.

California allergy serum benefit verification

State market plan benefit availability is subject to plan-specific verification.

State market plan enhancement: Members may have benefits for allergy serum, including injectable allergen or antigen extract, subject to the member's Evidence of Coverage or Schedule of Benefits or confirmation from Customer Service.

Plan-specific provisions govern if they differ from this policy.

Cytotoxicity testing, including Bryan's test, is not covered.

Skin end point titration, including the Rinkel method, is not covered.

Urine auto-injection therapy is not covered.

Documentation and Coverage Verification

Documentation Required

Established Treatment Plan

Document an established treatment plan supporting allergy treatment, including allergen/antigen immunotherapy and allergy serum when applicable.

Include the services and supplies needed to determine and provide appropriate allergy treatment.
Document the treatment plan for allergy serum and related administration supplies when applicable.

Documentation Required

RAST Documentation Required

When RAST is used, document that skin testing was unsuccessful or not tolerated because of an existing skin condition.

RAST is an additional test that may be used when the stated skin-testing conditions apply.

Billing Rule

Verify Benefit Eligibility

Verify and document the member's benefit eligibility before rendering allergy serum, testing, treatment, or related services.

Review the member's Evidence of Coverage (EOC) and Schedule of Benefits (SOB).
Check applicable state market plan provisions or contact the Customer Service Department to determine coverage eligibility.
Allergy serum benefits may be available under state market plan enhancements.

Billing Rule

Use a UnitedHealthcare Network Physician

Obtain allergy serum, including needles, syringes, and other supplies for serum administration, through a UnitedHealthcare network physician.

Network-physician sourcing applies to allergy serum and its administration supplies.

Documentation Required

Established Treatment Plan and Medical Necessity

Provide allergy treatment services, allergen/antigen immunotherapy, and serum under an established treatment plan and ensure that all services are medically necessary.

Document the established treatment plan supporting the treatment and supplies.
Confirm medical necessity for all services.

Denial Risk

Non-Covered Allergy Tests and Services

Do not submit the following tests or services as covered allergy benefits; they are non-covered, including when listed as examples rather than an exhaustive list.

Cytotoxicity testing, such as Bryan's test
Skin end point titration, such as the Rinkel method
Urine auto-injection therapy

Billing Rule

Member Plan Provisions Govern

Coverage is governed by the member's benefit plan provisions. Verify eligibility, limitations, exclusions, and applicable benefits against the member's Evidence of Coverage or Schedule of Benefits before providing services.

Covered benefits may be listed in Federal/State Mandated Regulations, State Market Plan Enhancements, and Covered Benefits sections.
If this policy conflicts with the member's EOC/SOB, the member's EOC/SOB provision governs.

Policy Scope and Clinical Context

This policy addresses diagnostic allergy testing used to determine appropriate treatment, as well as allergy serum, supplies, and treatment services, including allergen or antigen immunotherapy. Covered evaluation may include provocative antigen testing, skin testing, selected laboratory testing, chest radiography when respiratory symptoms are present, and RAST when skin testing is unsuccessful or not tolerated because of an existing skin condition. Coverage is subject to medical necessity, the member's plan provisions, network requirements, and an established treatment plan.